Canada Genome Editing Market Size & Outlook, 2023-2030
Canada genome editing market, 2018-2030 (US$M)
Related Markets
Canada genome editing market highlights
- The Canada genome editing market generated a revenue of USD 307.4 million in 2023 and is expected to reach USD 1,028.1 million by 2030.
- The Canada market is expected to grow at a CAGR of 18.8% from 2024 to 2030.
- In terms of segment, (crispr)/cas9 was the largest revenue generating technology in 2023.
- (CRISPR)/Cas9 is the most lucrative technology segment registering the fastest growth during the forecast period.
Genome editing market data book summary
| Market revenue in 2023 | USD 307.4 million |
| Market revenue in 2030 | USD 1,028.1 million |
| Growth rate | 18.8% (CAGR from 2023 to 2030) |
| Largest segment | (crispr)/cas9 |
| Fastest growing segment | (CRISPR)/Cas9 |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
| Key market players worldwide | Merck KGaA, Cibus Inc Ordinary Shares - Class A, Recombinetics, Sangamo Therapeutics Inc, Editas Medicine Inc, Precision BioSciences Inc, CRISPR Therapeutics AG, Intellia Therapeutics Inc, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, AstraZeneca PLC, Takara Bio Inc, Horizon Discovery, Danaher Corp, Genscript Biotech Corp Class H, New England Biolabs, Origene Technologies, Bluebird bio Inc, Lonza Group Ltd, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, Canada accounted for 3.9% of the global genome editing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. genome editing market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,028.1 million by 2030.
(crispr)/cas9 was the largest segment with a revenue share of 42.81% in 2023. Horizon Databook has segmented the Canada genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2018 to 2030.
Robust and coordinated government support is anticipated to drive market growth in the country. For instance, in July 2021, Genome Canada announced that the Canadian federal government, along with several partners, committed USD 47.7 million to fund eight applied research projects utilizing genomics, within Canada’s natural resources and environmental sectors.
The collaboration between private players and nonprofit organizations to accelerate the development of stem cell-based therapies is expected to drive the market. For instance, in April 2020, Toronto-based panCELLa collaborated with the Center for Commercialization of Regenerative Medicine (CCRM).
This agreement was aimed at producing commercial-use and clinical-grade induced pluripotent stem cell lines, which will be made available to industry and academia to facilitate development of new therapies.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genome Editing Market Scope
Genome Editing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada genome editing market size, by technology, 2018-2030 (US$M)
Canada Genome Editing Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
